bf/NYSE:ABBV_icon.jpeg

NYSE:ABBV

AbbVie Inc.

  • Stock

USD

Last Close

166.41

22/04 16:19

Market Cap

290.25B

Beta: 0.55

Volume Today

1.60M

Avg: 6.07M

PE Ratio

46.58

PFCF: 12.27

Dividend Yield

3.48%

Payout:159.95%

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Drug Manufacturers / General
  • website

    www.abbvie.com
  • crunchbase

    abbvie
  • ipo date

    Jan 02, 2013

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients;...Show More

Earnings per Share (Estimate*)

12342015-07-242017-07-282019-07-262021-07-302023-07-27

Revenue (Estimate*)

5B10B15B2015-07-242017-07-282019-07-262021-07-302023-07-27

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.